SHAWNA GLEASON: Open Payments
NPI 1396037172 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,313 in 61 payments from 17 companies in 2025. Trend: 2023 $1,285 · 2024 $1,322 · 2025 $1,313
Food & beverage: $1,313
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $453 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $128 |
| Vanda Pharmaceuticals Inc. | 1 | $107 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| GlaxoSmithKline, LLC. | 3 | $68 |
| Amgen Inc. | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Dexcom, Inc. | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Corcept Therapeutics | 2 | $39 |
Products named: QULIPTA, CAPLYTA, FANAPT, VRAYLAR, Auvelity, TRELEGY ELLIPTA, OTEZLA, TRINTELLIX.
Industry payments across MI — which companies pay providers there.
